Surface decoration of red blood cells with maleimidophenyl-polyethylene glycol facilitated by thiolation with iminothiolane: An approach to mask A, B, and D antigens to generate universal red blood cells

Transfusion

Volumn 45, Issue 3, 2005, Pages 374-383

  Nacharaju, Parimala ^b   Boctor, Fouad N ^b   Manjula, Belur N ^b   Acharya, Seetharama A ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD GROUP A ANTIGEN; BLOOD GROUP B ANTIGEN; IMINOTHIOL; MACROGOL; MALEIMIDOPHENYL POLYETHYLENE GLYCOL; RHESUS D ANTIGEN; UNCLASSIFIED DRUG;

ALLOIMMUNIZATION; ARTICLE; BLOOD GROUP RHESUS SYSTEM; BLOOD TRANSFUSION; CONTROLLED STUDY; EPITOPE MAPPING; ERYTHROCYTE; FLOW CYTOMETRY; HEMAGGLUTINATION INHIBITION; HUMAN; MASKING;

ABO BLOOD-GROUP SYSTEM; ANTIBODY SPECIFICITY; BLOOD BANKS; EPITOPES; ERYTHROCYTES; FLOW CYTOMETRY; HUMANS; MALEIMIDES; MOLECULAR WEIGHT; POLYETHYLENE GLYCOLS; RH-HR BLOOD-GROUP SYSTEM; SULFHYDRYL COMPOUNDS;

EID: 15244343341     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2005.04290.x     Document Type: Article

References (32)

1. Pretransfusion testing. In: Brecher ME, eds. Technical manual. 14th ed. Bethesda: American Association of Blood Banks; 2002. p. 379-92.
2. Blumberg N, Ross K, Avila E, Peck K. Should chronic transfusion be matched for antigens other than ABO and Rho(D)? Vox Sang 1984;47:205-8.
3. Vichinsky EP, Earles A, Johnson RA, et al. Alloimmunization in sickle cell anemia and transfusion of racially unmatched blood. N Engl J Med 1990;322:1617-21.
4. Castro O, Sandler SG, Houston Yu P, Rana S. Predicting the effect of transfusing only phenotype-matched RBCs to patients with sickle cell disease: theoretical and practical implications. Transfusion 2002;42:684-90.
5. Sosler SD, Jilly BJ, Saporito C, Koshy M. A simple, practical model for reducing alloimmunization in patients with sickle cell disease. Am J Hematol 1993;43:103-6.
6. Issitt PD. Race-related red cell alloantibody problems. Br J Biomed Sci 1994;51:158-67.
7. The Rh system. In: Brecher ME, eds. Technical manual. 14th ed. Bethesda: American Association of Blood Banks; 2002. p. 295-313.
8. Goldstein J, Siviglia G, Hurst R, Lenny L, Reich L. Group B erythrocytes enzymatically converted to group O survive normally in A, B, and O individuals. Science 1982;215:168-70.
9. Jeong ST, Byun SM. Decreased agglutination of methoxypolyethylene glycol attached red blood cells: significance as a blood substitute. Artif Cells Blood Substit Immobil Biotechnol 1996;24:503-11.
10. Scott MD, Murad KL, Koumpouras F, Talbot M, Eaton JW. Chemical camouflage of antigenic determinants: stealth erythrocytes. Proc Natl Acad Sci U S A 1997;94:7566-71.
11. Fisher TC, Armstrong JK, inventors. Red blood cells covalently bound with two different polyethylene glycol derivatives. US patent 6312685. 2001.
12. Bradley AJ, Murad KL, Regan KL, Scott MD. Biophysical consequences of linker chemistry and polymer size on stealth erythrocytes: size does matter. Biochim Biophys Acta 2002;1561:147-58.
13. Lenny LL, Hurst R, Goldstein J, Galbraith RA. Transfusions to group O subjects of 2 units of red cells enzymatically converted from group B to group O. Transfusion 1994;34:209-14.
14. Lenny LL, Hurst R, Zhu A, Goldstein J, Galbraith RA. Multiple-unit and second transfusions of red cells enzymatically converted from group B to group O: report on the end of phase 1 trials. Transfusion 1995;35:899-902.
15. Olsson ML, Hill CA, de la Vega H, et al. Universal red blood cells - enzymatic conversion of blood group A and B antigens. Transfus Clin Biol 2004;11:33-9.
16. Avent ND, Reid ME. The Rh blood group system: a review. Blood 2000;95:375-87.
17. Sabolovic D, Sestier C, Perrotin P, et al. Covalent binding of polyethylene glycol to the surface of red blood cells as detected and followed up by cell electrophoresis and rheological methods. Electrophoresis 2000;21:301-6.
18. Blackall DP, Armstrong JK, Meiselman HJ, Fisher TC. Polyethylene glycol-coated red blood cells fail to bind glycophorin A-specific antibodies and are impervious to invasion by the Plasmodium falciparum malaria parasite. Blood 2001;97:551-6.
19. Bradley AJ, Test ST, Murad KL, Mitsuyoshi J, Scott MD. Interactions of IgM ABO antibodies and complement with methoxy-PEG-modified human RBCs. Transfusion 2001;41:1225-33.
20. Roberts MJ, Bentley MD, Harris JM. Chemistry for peptide and protein PEGylation. Adv Drug Delivery Rev 2002;54:459-76.
21. Acharya AS, Manjula BN, Smith PK, inventors. Hemoglobin crosslinkers. US patent 5585484. Albert Einstein College of Medicine 1996.
22. Manjula BN, Tsai A, Upadhya R, et al. Site-specific PEGylation of hemoglobin at Cys-93 (beta): correlation between the colligative properties of the PEGylated protein and the length of the conjugated PEG chain. Bioconjug Chem 2003;14:464-72.
23. de Isla NG, Riquelme BD, Rasia RJ, Valverde JR, Stoltz JF. Quantification of glycophorin A and glycophorin B on normal human RBCs by flow cytometry. Transfusion 2003;43:1145-52.
24. Hoskins LC, Larson G, Naff GB. Blood group A immunodeterminants on human red cells differ in biologic activity and sensitivity to alpha-N- acetylgalactosaminidase. Transfusion 1995;35:813-21.
25. Mathur S, Clark B, Castro G, et al. Efficient full unit PEGylation of human red blood cells (RBC) using linear methoxy-capped polyethylene glycol (mPEG). Blood 2003;102:556A.
26. Juszczak LJ, Manjula B, Bonaventura C, Acharya SA, Friedman JM. UV resonance Raman study of beta93-modified hemoglobin A: chemical modifier-specific effects and added influences of attached poly(ethylene glycol) chains. Biochemistry 2002;41:376-85.
27. Abuchowski A, van Es T, Palczuk NC, Davis FF. Alteration of immunological properties of bovine serum albumin by covalent attachment of polyethylene glycol. J Biol Chem 1977;252:3578-81.
28. Abuchowski A, McCoy JR, Palczuk NC, van Es T, Davis FF. Effect of covalent attachment of polyethylene glycol on immunogenicity and circulating life of bovine liver catalase. J Biol Chem 1977;252:3582-6.
29. Richter AW, Akerblom E. Antibodies against polyethylene glycol produced in animals by immunization with monomethoxy polyethylene glycol modified proteins. Int Arch Allergy Appl Immunol 1983;70:124-31.
30. Armstrong JK, Leger R, Wenby RB, et al. Occurrence of an antibody to polyethylene glycol in normal donors. Blood 2003;102:556A.
31. Armstrong JK, Arndt PA, Leger RM, et al. Reduction of autologous IgG uptake by polyethylene glycol-coated red blood cells. Transfusion 2000;40:121S.
32. Huang ST, Huang Z, Marques MB, Prchal JT. Adding methoxy polyethylene glycol to red blood cells coated with crosslinked polyethylene glycol-albumin prevents reaction with naturally occurring antibodies while preserving red cell oxygen carrying capacity. Transfusion 1999;39:80S.